Alterity Therapeutics
ATHE----
Forecast & Rating4 analysts currently cover Alterity Therapeutics, of which 4 give a positive rating. The average price target is $13.25, about 331.6% upside from the current price of $3.07. Coverage is limited, so the data is for reference only. Data as of Sep 1, 2026; this does not constitute investment advice.
Sep 1, 2026Price forecast
$13.25331.60%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateOct 5, 2026
Forecast met15.2%
Stock price$3.07
Avg. target$12.0
High target$12
Low target$12
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.